IL6 and metabolic dysfunction-associated steatohepatitis: The gene expression of IL-6 and TNF-α further demonstrated the ability of phloretin to diminish hepatic inflammation and consequently prevent the progression of NASH in mice (p < 0.001; Figure 2I).